Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy

Mara Sherman, Ruth T. Yu, Dannielle D. Engle, Ning Ding, Annette R. Atkins, Herve Tiriac, Eric A. Collisson, Frances Connor, Terry Van Dyke, Serguei Kozlov, Philip Martin, Tiffany W. Tseng, David W. Dawson, Timothy R. Donahue, Atsushi Masamune, Tooru Shimosegawa, Minoti V. Apte, Jeremy S. Wilson, Beverly Ng, Sue Lynn LauJenny E. Gunton, Geoffrey M. Wahl, Tony Hunter, Jeffrey A. Drebin, Peter J. O'Dwyer, Christopher Liddle, David A. Tuveson, Michael Downes, Ronald M. Evans

Research output: Contribution to journalArticle

349 Citations (Scopus)

Abstract

The poor clinical outcome in pancreatic ductal adenocarcinoma (PDA) is attributed to intrinsic chemoresistance and a growth-permissive tumor microenvironment. Conversion of quiescent to activated pancreatic stellate cells (PSCs) drives the severe stromal reaction that characterizes PDA. Here, we reveal that the vitamin D receptor (VDR) is expressed in stroma from human pancreatic tumors and that treatment with the VDR ligand calcipotriol markedly reduced markers of inflammation and fibrosis in pancreatitis and human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in induced stromal remodeling, increased intratumoral gemcitabine, reduced tumor volume, and a 57% increase in survival compared to chemotherapy alone. This work describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response and suggests vitamin D priming as an adjunct in PDA therapy. PaperFlick

Original languageEnglish (US)
Pages (from-to)80-93
Number of pages14
JournalCell
Volume159
Issue number1
DOIs
StatePublished - Sep 25 2014
Externally publishedYes

Fingerprint

Calcitriol Receptors
Pancreatic Stellate Cells
Pancreatic Neoplasms
Pancreatitis
Tumors
Adenocarcinoma
gemcitabine
Neoplasms
Tumor Microenvironment
Tumor Burden
Vitamin D
Fibrosis
Therapeutics
Chemotherapy
Ligands
Inflammation
Drug Therapy
Survival
Growth

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. / Sherman, Mara; Yu, Ruth T.; Engle, Dannielle D.; Ding, Ning; Atkins, Annette R.; Tiriac, Herve; Collisson, Eric A.; Connor, Frances; Van Dyke, Terry; Kozlov, Serguei; Martin, Philip; Tseng, Tiffany W.; Dawson, David W.; Donahue, Timothy R.; Masamune, Atsushi; Shimosegawa, Tooru; Apte, Minoti V.; Wilson, Jeremy S.; Ng, Beverly; Lau, Sue Lynn; Gunton, Jenny E.; Wahl, Geoffrey M.; Hunter, Tony; Drebin, Jeffrey A.; O'Dwyer, Peter J.; Liddle, Christopher; Tuveson, David A.; Downes, Michael; Evans, Ronald M.

In: Cell, Vol. 159, No. 1, 25.09.2014, p. 80-93.

Research output: Contribution to journalArticle

Sherman, M, Yu, RT, Engle, DD, Ding, N, Atkins, AR, Tiriac, H, Collisson, EA, Connor, F, Van Dyke, T, Kozlov, S, Martin, P, Tseng, TW, Dawson, DW, Donahue, TR, Masamune, A, Shimosegawa, T, Apte, MV, Wilson, JS, Ng, B, Lau, SL, Gunton, JE, Wahl, GM, Hunter, T, Drebin, JA, O'Dwyer, PJ, Liddle, C, Tuveson, DA, Downes, M & Evans, RM 2014, 'Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy', Cell, vol. 159, no. 1, pp. 80-93. https://doi.org/10.1016/j.cell.2014.08.007
Sherman, Mara ; Yu, Ruth T. ; Engle, Dannielle D. ; Ding, Ning ; Atkins, Annette R. ; Tiriac, Herve ; Collisson, Eric A. ; Connor, Frances ; Van Dyke, Terry ; Kozlov, Serguei ; Martin, Philip ; Tseng, Tiffany W. ; Dawson, David W. ; Donahue, Timothy R. ; Masamune, Atsushi ; Shimosegawa, Tooru ; Apte, Minoti V. ; Wilson, Jeremy S. ; Ng, Beverly ; Lau, Sue Lynn ; Gunton, Jenny E. ; Wahl, Geoffrey M. ; Hunter, Tony ; Drebin, Jeffrey A. ; O'Dwyer, Peter J. ; Liddle, Christopher ; Tuveson, David A. ; Downes, Michael ; Evans, Ronald M. / Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. In: Cell. 2014 ; Vol. 159, No. 1. pp. 80-93.
@article{9f3a7f7d620149e38e7874260d33e6b4,
title = "Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy",
abstract = "The poor clinical outcome in pancreatic ductal adenocarcinoma (PDA) is attributed to intrinsic chemoresistance and a growth-permissive tumor microenvironment. Conversion of quiescent to activated pancreatic stellate cells (PSCs) drives the severe stromal reaction that characterizes PDA. Here, we reveal that the vitamin D receptor (VDR) is expressed in stroma from human pancreatic tumors and that treatment with the VDR ligand calcipotriol markedly reduced markers of inflammation and fibrosis in pancreatitis and human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in induced stromal remodeling, increased intratumoral gemcitabine, reduced tumor volume, and a 57{\%} increase in survival compared to chemotherapy alone. This work describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response and suggests vitamin D priming as an adjunct in PDA therapy. PaperFlick",
author = "Mara Sherman and Yu, {Ruth T.} and Engle, {Dannielle D.} and Ning Ding and Atkins, {Annette R.} and Herve Tiriac and Collisson, {Eric A.} and Frances Connor and {Van Dyke}, Terry and Serguei Kozlov and Philip Martin and Tseng, {Tiffany W.} and Dawson, {David W.} and Donahue, {Timothy R.} and Atsushi Masamune and Tooru Shimosegawa and Apte, {Minoti V.} and Wilson, {Jeremy S.} and Beverly Ng and Lau, {Sue Lynn} and Gunton, {Jenny E.} and Wahl, {Geoffrey M.} and Tony Hunter and Drebin, {Jeffrey A.} and O'Dwyer, {Peter J.} and Christopher Liddle and Tuveson, {David A.} and Michael Downes and Evans, {Ronald M.}",
year = "2014",
month = "9",
day = "25",
doi = "10.1016/j.cell.2014.08.007",
language = "English (US)",
volume = "159",
pages = "80--93",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy

AU - Sherman, Mara

AU - Yu, Ruth T.

AU - Engle, Dannielle D.

AU - Ding, Ning

AU - Atkins, Annette R.

AU - Tiriac, Herve

AU - Collisson, Eric A.

AU - Connor, Frances

AU - Van Dyke, Terry

AU - Kozlov, Serguei

AU - Martin, Philip

AU - Tseng, Tiffany W.

AU - Dawson, David W.

AU - Donahue, Timothy R.

AU - Masamune, Atsushi

AU - Shimosegawa, Tooru

AU - Apte, Minoti V.

AU - Wilson, Jeremy S.

AU - Ng, Beverly

AU - Lau, Sue Lynn

AU - Gunton, Jenny E.

AU - Wahl, Geoffrey M.

AU - Hunter, Tony

AU - Drebin, Jeffrey A.

AU - O'Dwyer, Peter J.

AU - Liddle, Christopher

AU - Tuveson, David A.

AU - Downes, Michael

AU - Evans, Ronald M.

PY - 2014/9/25

Y1 - 2014/9/25

N2 - The poor clinical outcome in pancreatic ductal adenocarcinoma (PDA) is attributed to intrinsic chemoresistance and a growth-permissive tumor microenvironment. Conversion of quiescent to activated pancreatic stellate cells (PSCs) drives the severe stromal reaction that characterizes PDA. Here, we reveal that the vitamin D receptor (VDR) is expressed in stroma from human pancreatic tumors and that treatment with the VDR ligand calcipotriol markedly reduced markers of inflammation and fibrosis in pancreatitis and human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in induced stromal remodeling, increased intratumoral gemcitabine, reduced tumor volume, and a 57% increase in survival compared to chemotherapy alone. This work describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response and suggests vitamin D priming as an adjunct in PDA therapy. PaperFlick

AB - The poor clinical outcome in pancreatic ductal adenocarcinoma (PDA) is attributed to intrinsic chemoresistance and a growth-permissive tumor microenvironment. Conversion of quiescent to activated pancreatic stellate cells (PSCs) drives the severe stromal reaction that characterizes PDA. Here, we reveal that the vitamin D receptor (VDR) is expressed in stroma from human pancreatic tumors and that treatment with the VDR ligand calcipotriol markedly reduced markers of inflammation and fibrosis in pancreatitis and human tumor stroma. We show that VDR acts as a master transcriptional regulator of PSCs to reprise the quiescent state, resulting in induced stromal remodeling, increased intratumoral gemcitabine, reduced tumor volume, and a 57% increase in survival compared to chemotherapy alone. This work describes a molecular strategy through which transcriptional reprogramming of tumor stroma enables chemotherapeutic response and suggests vitamin D priming as an adjunct in PDA therapy. PaperFlick

UR - http://www.scopus.com/inward/record.url?scp=84907485104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907485104&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2014.08.007

DO - 10.1016/j.cell.2014.08.007

M3 - Article

C2 - 25259922

AN - SCOPUS:84907485104

VL - 159

SP - 80

EP - 93

JO - Cell

JF - Cell

SN - 0092-8674

IS - 1

ER -